endoscopic surgery News
-
Robotics and endoscopic ear surgery
Introduction Pr Mohamed Badr-El-Dine (President of the IWGEES, President of the Egyptian Society of Skull Base Surgery) Pr Vincent Couloigner (Secretary-General SFORL, Paris, France) Mr Nicolas Prévost (CEO Collin SAS, Bagneux, France) RobOtol® assisted endoscopic surgery : feedback on the first patients Pr Yann Nguyen (Paris, France) Endoscopic otosclerosis surgery - ...
By Collin SAS
-
Hominis Used in First Transvaginal Robotic Hysterectomy in Belgium
In a first-of-its-kind procedure in Belgium, Dr. Jan Baekelandt of Bonheiden’s Imelda Hospital has performed a transvaginal robotic-assisted hysterectomy using Memic’s Hominis® technology. Dr. Baekelandt is a pioneering expert in gynecological oncology, and endoscopic and robotic surgery. His research focuses on transvaginal natural orifice transluminal endoscopic surgery ...
-
Ezisurg Medical presented at the European Bariatric Endoscopic Surgery Congress
On 23-24th September, 2021, the annual European Bariatric Endoscopic Surgery Trends (BEST) was successfully held in Montpellier, France. The BEST congress adopted a unique mode of online and offline access, bringing global experts and scholars together to discuss the cutting-edge progress in the field of bariatric surgery. Ezisurg Medical was honored to become the platinum partner of BEST, and ...
-
BioRegen attended the 28th Annual Congress of ESGE and held the European Distributors Training Meeting successfully in Thessaloniki, Greece
Thessaloniki, Greece, 6-9 October 2019. The 28th Annual Congress of European Society of Gynecologic Endoscopy (ESGE) was organized as scheduled in Thessaloniki, a beautiful city by the sea of Aegean and also the second biggest city of Greece. BioRegen has participated in this great international congress and received gynecologists, specialists and dealers from all over the world. The unique and ...
-
Medical today - Theramx, Exports ‘EG-Q Bond’, a Topical Skin Adhesive for epidermal bonding, to Spain(Europe)
Theramx announced on the 14th that it has signed an annual export contract with the Madrid Regional Health Agency, Spain, and has completed the delivery of the product. The product exported to Spain is EG-Q Bond, a bioadhesive for epidermal bonding that joins the affected area without using a separate suture for 20,000 endoscopic and laparoscopic surgeries. A Theramx official said, ...
By Theramx Inc.
-
AR and Navigation: the perfect medical tandem
The current global demand for cross-domain cooperation in the medical world has made some echo in a few companies from Taiwan. With the support of the Industrial Development Bureau of the Ministry of Economic Affairs, the Local Innovation Service Office of the Information Industry Development Association (Innovation Office of the Information Industry Association) and the Shuangho Hospital of the ...
By EPED Inc.
-
Amsel Medical wins FDA nod for Endo Occluder
Amsel Medical said today that it won FDA 510(k) clearance for its Amsel Endo Occluder device intended for occluding blood vessels during endoscopic procedures. The Cambridge, Mass.-based company touted that the clearance is the third the company has received from the FDA so far for its portfolio of occluder devices. The Amsel Endo Occluder is a mechanical occlusion clip delivered through a ...
-
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL Sinus Implant Reduces Healthcare Resource Utilization
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative period of 18 months, ...
-
First Implants of PROPEL Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe
Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken Wiesbaden in Germany was the first hospital outside the United States to offer the Company’s PROPEL® Contour (mometasone furoate) sinus implant following functional endoscopic ...
-
Wenzel Spine Announces Publication of Case Series Detailing Endoscopic Transforaminal Decompression and Fusion Technique with VariLift-LX
Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced a 24 Consecutive Patient Case Series detailing an endoscopic, stand-alone TLIF surgical technique used with the VariLift-LX System has been published in the Journal of Spine, Volume 7, Issue 2. The Case Series, authored by Kai-Uwe ...
-
`Scivita Medical Navigates Medical Innovation` Scivita 4K Ultra-High Definition Laparoscopy in Pediatric Surgery Seminar
On October 18. 2020. the online meeting of "Scivita Medical Navigates Medical Innovation' Scivita 4K Medical Ultra-high-definition Laparoscopy in Pediatric Surgery Seminar sponsored by Pediatric Surgery Branch of Guangdong Medical Association and undertook by Guangzhou Women and Children' s Medical Center was successfully held. The conference focused on how to effectively use endoscopy to ...
-
Intersect ENT Receives CE Mark Approval for PROPEL Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced it has received CE Mark approval for the company’s PROPEL Contour (mometasone furoate) sinus implant enabling sales and distribution in the European Union. The Contour CE approval expands the portfolio of PROPEL products ...
-
Mauna Kea Technologies Receives FDA 510(k) Clearance of Cellvizio® with a Fluorescent Dye, Fluorescein, as Drug Device Combination
The Cellvizio®100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries Mauna Kea Technologies today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Cellvizio® 100 series and all associated Confocal Miniprobes™ for ...
-
Large Complex Polyps Removed Successfully From Three Patients Without Surgical Intervention Using Lumendi Dilumen C2
A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue. The endolumenal ...
By Lumendi Ltd.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you